International Biotechnology (LON:IBT) Releases Earnings Results

International Biotechnology (LON:IBT) posted its quarterly earnings data on Tuesday. The company reported GBX (10.22) EPS for the quarter, Digital Look Earnings reports. The firm had revenue of GBX 46 million during the quarter. International Biotechnology had a net margin of 82.27% and a return on equity of 27.35%.

International Biotechnology Price Performance

LON:IBT opened at GBX 1,035.45 on Wednesday. The company has a debt-to-equity ratio of 9.43, a quick ratio of 0.32 and a current ratio of 0.11. International Biotechnology has a one year low of GBX 812 and a one year high of GBX 1,235. The stock has a 50 day moving average price of GBX 1,079.65 and a 200 day moving average price of GBX 1,010.15. The stock has a market cap of £327.75 million, a PE ratio of 4.28 and a beta of 0.47.

International Biotechnology Company Profile

The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies.

The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services.